BUSINESS
Wegovy
BUSINESS
Wegovy-maker Novo Nordisk to cut 9,000 jobs in restructuring
WORLD
WHO backs weight-loss drugs, urges cheap generics
BUSINESS
Novo Nordisk woes prompt Denmark to slash country’s 2025 growth forecast
BUSINESS
Wegovy maker Novo Nordisk to reduce costs after US$95bil stock loss
BUSINESS
Novo Nordisk’s shares extend losses, erasing nearly all gains since Wegovy launch
BUSINESS
India’s Biocon aims to lead copycat Wegovy sales in Canada from next year
BUSINESS
Obesity drug maker Novo Nordisk ousts CEO as competition weighs
BUSINESS
Big pharma fears best-selling drugs in crosshairs of US-EU tariff spat
BUSINESS
Nestle launches foods for weight loss drug users in US
BUSINESS
Novo Nordisk raises outlook fuelled by obesity drug demand
BUSINESS
Wegovy to be covered by US Medicare for heart disease patients
BUSINESS
US FDA approves Wegovy for lowering stroke, heart attack risks
BUSINESS
Novo Nordisk eyes China approval for weight loss drug Wegovy
BUSINESS
Novo Nordisk’s Wegovy success spurs cardiovascular disease focus
BUSINESS
Indian pharma joins Wegovy weight-loss craze with generics
BUSINESS
Studies link Ozempic, Wegovy to post-hip replacement benefits
BUSINESS
Novo sues Florida pharmacies over false product claims
BUSINESS
Novo to launch Wegovy in Asia in Feb 2024
BUSINESS
Novo Nordisk invests US$2.3bil in France to boost output
BUSINESS
Wegovy’s heart-protective benefits due to more than weight loss, says Novo
BUSINESS
Lilly’s weight-loss drug Zepbound gets US, UK approval to rival Wegovy
BUSINESS
Novo Nordisk’s earnings surge on Wegovy obesity drugs frenzy
BUSINESS